Dr. Nassir Marrouche is director of the Heart and Vascular Institute at Tulane University with a subspecialty in ...

Check out our curated selection of the best fitness trackers currently available on the market to help you reach your health ...

Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA® home sleep apnea test.

Healthcare in 2025 saw rapid innovation, rising costs, ACA subsidy expiration, AI adoption, consolidation, and affordability ...

Smartwatches and wearable heart monitors can help detect issues such as irregular heart rhythms. But they also have limits ...

Introduction Atrial fibrillation (AF) is the leading cause of cardioembolic stroke and is associated with increased stroke severity and fatality. Early identification of AF is essential for adequate ...

Rising rates of heart rhythm problems are colliding with an aging population and crowded hospitals. At the same time, many ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...

Contemporary cardiology faces a paradox: unprecedented technological capability coincides with declining scientific curiosity ...

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...